BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19223733)

  • 1. [An appropriate chemotherapy for esophageal cancer from a histological standpoint].
    Hayashi K; Nakamura T; Narumiya K; Yamamoto M
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):182-6. PubMed ID: 19223733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials for esophageal carcinoma.
    Miller DL
    Chest Surg Clin N Am; 2000 Aug; 10(3):583-90. PubMed ID: 10967759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined therapy of inoperable esophageal cancer].
    Fink U; Pfeiffer G; Gossmann A; Lukas P; Wilke HJ; Preusser P; Siewert JR
    Z Gastroenterol Verh; 1991 Mar; 26():209-16. PubMed ID: 1714151
    [No Abstract]   [Full Text] [Related]  

  • 4. Multidisciplinary management of early and locally advanced esophageal cancer.
    Kaifi JT; Gusani NJ; Jiang Y; Mackley HB; Dye CE; Mathew A; Kimchi ET; Reed MF; Staveley-O'Carroll KF
    J Clin Gastroenterol; 2011; 45(5):391-9. PubMed ID: 21301357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001.
    Kenjo M; Uno T; Murakami Y; Nagata Y; Oguchi M; Saito S; Numasaki H; Teshima T; Mitsumori M
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):357-63. PubMed ID: 19735863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal cancer: current and emerging therapy modalities.
    Ekman S; Dreilich M; Lennartsson J; Wallner B; Brattström D; Sundbom M; Bergqvist M
    Expert Rev Anticancer Ther; 2008 Sep; 8(9):1433-48. PubMed ID: 18759695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy of esophageal cancer].
    Herrmann R
    Z Gastroenterol Verh; 1989 Jul; 24():56-7. PubMed ID: 2474987
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic treatment for oesophageal cancer.
    van Meerten E; van der Gaast A
    Eur J Cancer; 2005 Mar; 41(5):664-72. PubMed ID: 15763640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of preoperative chemotherapy for esophageal cancer: when is surgery alone feasible?
    Chong G; Cunningham D
    Nat Clin Pract Oncol; 2005 Apr; 2(4):172-3. PubMed ID: 16264912
    [No Abstract]   [Full Text] [Related]  

  • 10. Salvage surgery for esophageal carcinoma after definitive chemoradiation therapy.
    Matsubara H
    Ann Thorac Cardiovasc Surg; 2007 Oct; 13(5):293-5. PubMed ID: 17954984
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular biological challenges in he treatment of esophageal adenocarcinoma.
    Boonstra JJ; Dinjens WN; Tilanus HW; Koppert LB
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):275-86. PubMed ID: 19072420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
    Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative therapy for esophageal cancer.
    Ku GY; Ilson DH
    Gastroenterol Clin North Am; 2009 Mar; 38(1):135-52, ix. PubMed ID: 19327572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708).
    Kato H; Sato A; Fukuda H; Kagami Y; Udagawa H; Togo A; Ando N; Tanaka O; Shinoda M; Yamana H; Ishikura S
    Jpn J Clin Oncol; 2009 Oct; 39(10):638-43. PubMed ID: 19549720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy.
    Sakaeda T; Yamamori M; Kuwahara A; Nishiguchi K
    Adv Drug Deliv Rev; 2009 May; 61(5):388-401. PubMed ID: 19135108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case 19-2009: Carcinoma of the gastroesophageal junction.
    van der Vliet HJ; van der Peet DL; Verheul HM
    N Engl J Med; 2009 Sep; 361(13):1315; author reply 1315-6. PubMed ID: 19776417
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging drugs for esophageal cancer.
    Homs MY; Voest EE; Siersema PD
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):329-39. PubMed ID: 19453287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary.
    Ajani JA
    Semin Oncol; 1994 Aug; 21(4):474-82. PubMed ID: 8042045
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
    Chang DT; Chapman C; Shen J; Su Z; Koong AC
    Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative versus postoperative chemoradiotherapy in the trimodality management of esophageal cancer.
    Kim C; Monjazeb AM; Suntharalingam M; Giesinger KR; Blackstock AW
    Clin Adv Hematol Oncol; 2009 May; 7(5):327-333, 342. PubMed ID: 19521322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.